Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.